A citation-based method for searching scientific literature

Denis Horgan, Giuseppe Curigliano, Olaf Rieß, Paul Hofman, Reinhard Büttner, Pierfranco Conte, Tanja Cufer, William M Gallagher, Nadia Georges, Keith Kerr, Frédérique Penault-Llorca, Ken Mastris, Carla Pinto, Jan Van Meerbeeck, Elisabetta Munzone, Marlene Thomas, Sonia Ujupan, Gilad W Vainer, Janna-Lisa Velthaus, Fabrice André. J Pers Med 2022
Times Cited: 9







List of co-cited articles
54 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer.
Christian Rolfo, Philip Mack, Giorgio V Scagliotti, Charu Aggarwal, Maria E Arcila, Fabrice Barlesi, Trever Bivona, Maximilian Diehn, Caroline Dive, Rafal Dziadziuszko,[...]. J Thorac Oncol 2021
98
44

Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer.
E Heitzer, D van den Broek, M G Denis, P Hofman, M Hubank, F Mouliere, L Paz-Ares, E Schuuring, H Sültmann, G Vainer,[...]. ESMO Open 2022
16
44

The Effect of Advances in Lung-Cancer Treatment on Population Mortality.
Nadia Howlader, Gonçalo Forjaz, Meghan J Mooradian, Rafael Meza, Chung Yin Kong, Kathleen A Cronin, Angela B Mariotto, Douglas R Lowy, Eric J Feuer. N Engl J Med 2020
416
33

Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
Nasser H Hanna, Andrew G Robinson, Sarah Temin, Sherman Baker, Julie R Brahmer, Peter M Ellis, Laurie E Gaspar, Rami Y Haddad, Paul J Hesketh, Dharamvir Jain,[...]. J Clin Oncol 2021
102
33

Clinical utility of reflex testing using focused next-generation sequencing for management of patients with advanced lung adenocarcinoma.
Tyler E Miller, Michael Yang, David Bajor, Judah D Friedman, Richard Y C Chang, Afshin Dowlati, Joseph E Willis, Navid Sadri. J Clin Pathol 2018
22
33

Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.
F Mosele, J Remon, J Mateo, C B Westphalen, F Barlesi, M P Lolkema, N Normanno, A Scarpa, M Robson, F Meric-Bernstam,[...]. Ann Oncol 2020
289
33


Fusion-positive non-small cell lung carcinoma: Biological principles, clinical practice, and diagnostic implications.
Daniel Kazdal, Véronique Hofman, Petros Christopoulos, Marius Ilié, Albrecht Stenzinger, Paul Hofman. Genes Chromosomes Cancer 2022
9
33

The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients.
Lei Cai, Yong Chen, Xiaoling Tong, Xue Wu, Hua Bao, Yang Shao, Zhuang Luo, Xuming Wang, Yang Cao. Int J Cancer 2021
6
33

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials.
Robert C Doebele, Alexander Drilon, Luis Paz-Ares, Salvatore Siena, Alice T Shaw, Anna F Farago, Collin M Blakely, Takashi Seto, Byung Chul Cho, Diego Tosi,[...]. Lancet Oncol 2020
535
22

Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.
Yi-Long Wu, Masahiro Tsuboi, Jie He, Thomas John, Christian Grohe, Margarita Majem, Jonathan W Goldman, Konstantin Laktionov, Sang-We Kim, Terufumi Kato,[...]. N Engl J Med 2020
498
22

ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research.
C Marchiò, M Scaltriti, M Ladanyi, A J Iafrate, F Bibeau, M Dietel, J F Hechtman, T Troiani, F López-Rios, J-Y Douillard,[...]. Ann Oncol 2019
163
22

Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study.
Justin F Gainor, Giuseppe Curigliano, Dong-Wan Kim, Dae Ho Lee, Benjamin Besse, Christina S Baik, Robert C Doebele, Philippe A Cassier, Gilberto Lopes, Daniel S W Tan,[...]. Lancet Oncol 2021
79
22

Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315).
Frank Griesinger, Wilfried Eberhardt, Arnd Nusch, Marcel Reiser, Mark-Oliver Zahn, Christoph Maintz, Christiane Bernhardt, Christoph Losem, Albrecht Stenzinger, Lukas C Heukamp,[...]. Lung Cancer 2021
21
22

Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases.
Anna-Lena Volckmar, Jonas Leichsenring, Martina Kirchner, Petros Christopoulos, Olaf Neumann, Jan Budczies, Cristiano Manuel Morais de Oliveira, Eugen Rempel, Ivo Buchhalter, Regine Brandt,[...]. Int J Cancer 2019
59
22

Targeted Next-Generation Sequencing Analysis for Recurrence in Early-Stage Lung Adenocarcinoma.
In Ae Kim, Jae Young Hur, Hee Joung Kim, Jung Hoon Park, Jae Joon Hwang, Song Am Lee, Seung Eun Lee, Wan Seop Kim, Kye Young Lee. Ann Surg Oncol 2021
19
22

Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients.
Véronique Hofman, Isabelle Rouquette, Elodie Long-Mira, Nicolas Piton, Emmanuel Chamorey, Simon Heeke, Jean Michel Vignaud, Clémence Yguel, Julien Mazières, Anne-Laure Lepage,[...]. J Thorac Oncol 2019
26
22


Molecular characteristics and clinical outcomes of complex ALK rearrangements identified by next-generation sequencing in non-small cell lung cancers.
Peiyi Xia, Lan Zhang, Pan Li, Enjie Liu, Wencai Li, Jianying Zhang, Hui Li, Xiaoxing Su, Guozhong Jiang. J Transl Med 2021
12
22

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry.
J Mazieres, A Drilon, A Lusque, L Mhanna, A B Cortot, L Mezquita, A A Thai, C Mascaux, S Couraud, R Veillon,[...]. Ann Oncol 2019
474
22

The Genomic Landscape of SMARCA4 Alterations and Associations with Outcomes in Patients with Lung Cancer.
Adam J Schoenfeld, Chai Bandlamudi, Jessica A Lavery, Joseph Montecalvo, Azadeh Namakydoust, Hira Rizvi, Jacklynn Egger, Carla P Concepcion, Sonal Paul, Maria E Arcila,[...]. Clin Cancer Res 2020
62
22

Sotorasib for Lung Cancers with KRAS p.G12C Mutation.
Ferdinandos Skoulidis, Bob T Li, Grace K Dy, Timothy J Price, Gerald S Falchook, Jürgen Wolf, Antoine Italiano, Martin Schuler, Hossein Borghaei, Fabrice Barlesi,[...]. N Engl J Med 2021
295
22


Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status.
Biagio Ricciuti, Kathryn C Arbour, Jessica J Lin, Amir Vajdi, Natalie Vokes, Lingzhi Hong, Jianjun Zhang, Michael Y Tolstorukov, Yvonne Y Li, Liam F Spurr,[...]. J Thorac Oncol 2022
39
22

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.
Jason D Merker, Geoffrey R Oxnard, Carolyn Compton, Maximilian Diehn, Patricia Hurley, Alexander J Lazar, Neal Lindeman, Christina M Lockwood, Alex J Rai, Richard L Schilsky,[...]. J Clin Oncol 2018
478
22

Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy.
Ferdinandos Skoulidis, John V Heymach. Nat Rev Cancer 2019
317
22

Predictive molecular pathology in non-small cell lung cancer in France: The past, the present and the perspectives.
Paul Hofman, Etienne Rouleau, Jean-Christophe Sabourin, Marc Denis, Jean-François Deleuze, Fabrice Barlesi, Pierre Laurent-Puig. Cancer Cytopathol 2020
8
25


Lung cancer biomarker testing: perspective from Europe.
Erik Thunnissen, Birgit Weynand, Dalma Udovicic-Gagula, Luka Brcic, Malgorzata Szolkowska, Paul Hofman, Silvana Smojver-Ježek, Sisko Anttila, Fiorella Calabrese, Izidor Kern,[...]. Transl Lung Cancer Res 2020
15
22


The Importance of STK11/LKB1 Assessment in Non-Small Cell Lung Carcinomas.
Baharia Mograbi, Simon Heeke, Paul Hofman. Diagnostics (Basel) 2021
13
22

Next Generation Sequencing for Gene Fusion Analysis in Lung Cancer: A Literature Review.
Rossella Bruno, Gabriella Fontanini. Diagnostics (Basel) 2020
44
22

Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer.
Julia Judd, Nagla Abdel Karim, Hina Khan, Abdul Rafeh Naqash, Yasmine Baca, Joanne Xiu, Ari M VanderWalde, Hirva Mamdani, Luis E Raez, Misako Nagasaka,[...]. Mol Cancer Ther 2021
16
22

The evolving landscape of biomarker testing for non-small cell lung cancer in Europe.
Keith M Kerr, Frédéric Bibeau, Erik Thunnissen, Johan Botling, Aleš Ryška, Jürgen Wolf, Katarina Öhrling, Peter Burdon, Umberto Malapelle, Reinhard Büttner. Lung Cancer 2021
49
22

Two Patients With Advanced-Stage Lung Adenocarcinoma With Radiologic Complete Response to Nivolumab Treatment Harboring an STK11/LKB1 Mutation.
Ernest Nadal, Simon Heeke, Jonathan Benzaquen, Noelia Vilariño, Arturo Navarro, Daniel Azuara, Mar Varela, Josiane Otto, Nuria Baixeras, David Shahbazian,[...]. JCO Precis Oncol 2020
4
50

The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancer.
Barbara Melosky, Paul Wheatley-Price, Rosalyn A Juergens, Adrian Sacher, Natasha B Leighl, Ming-Sound Tsao, Parneet Cheema, Stephanie Snow, Geoffrey Liu, Paul B Card,[...]. Lung Cancer 2021
19
22

Expanding the Reach of Precision Oncology by Drugging All KRAS Mutants.
Marco H Hofmann, Daniel Gerlach, Sandra Misale, Mark Petronczki, Norbert Kraut. Cancer Discov 2022
22
22


Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study.
Keunchil Park, Eric B Haura, Natasha B Leighl, Paul Mitchell, Catherine A Shu, Nicolas Girard, Santiago Viteri, Ji-Youn Han, Sang-We Kim, Chee Khoon Lee,[...]. J Clin Oncol 2021
115
22

Strategies for the successful implementation of plasma-based NSCLC genotyping in clinical practice.
Charu Aggarwal, Christian D Rolfo, Geoffrey R Oxnard, Jhanelle E Gray, Lynette M Sholl, David R Gandara. Nat Rev Clin Oncol 2021
49
22

Liquid biopsy enters the clinic - implementation issues and future challenges.
Michail Ignatiadis, George W Sledge, Stefanie S Jeffrey. Nat Rev Clin Oncol 2021
250
22

Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing.
Danielle Cohen, Liesbeth M Hondelink, Nienke Solleveld-Westerink, Sandra M Uljee, Dina Ruano, Anne-Marie Cleton-Jansen, Jan H von der Thüsen, S Rajen S Ramai, Pieter E Postmus, Jacob F Graadt van Roggen,[...]. J Thorac Oncol 2020
42
22

Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients.
M Ilie, E Long, V Hofman, B Dadone, C H Marquette, J Mouroux, J M Vignaud, H Begueret, J P Merlio, D Capper,[...]. Ann Oncol 2013
90
22

Clinical Utility of Rapid EGFR Genotyping in Advanced Lung Cancer.
Ibiayi Dagogo-Jack, Christopher G Azzolli, Florian Fintelmann, Mari Mino-Kenudson, Anna F Farago, Justin F Gainor, Ginger Jiang, Zofia Piotrowska, Rebecca S Heist, Inga T Lennes,[...]. JCO Precis Oncol 2018
18
22

Economic Impact of Next-Generation Sequencing Versus Single-Gene Testing to Detect Genomic Alterations in Metastatic Non-Small-Cell Lung Cancer Using a Decision Analytic Model.
Nathan A Pennell, Alex Mutebi, Zheng-Yi Zhou, Marie Louise Ricculli, Wenxi Tang, Helen Wang, Annie Guerin, Tom Arnhart, Anand Dalal, Medha Sasane,[...]. JCO Precis Oncol 2019
29
22

Cost Effectiveness of Multigene Panel Sequencing for Patients With Advanced Non-Small-Cell Lung Cancer.
Lotte Steuten, Bernardo Goulart, Neal J Meropol, Daryl Pritchard, Scott D Ramsey. JCO Clin Cancer Inform 2019
36
22

Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients.
Luciene Schluckebier, Rosangela Caetano, Osvaldo Ulises Garay, Giuliana T Montenegro, Marcelo Custodio, Veronica Aran, Carlos Gil Ferreira. BMC Cancer 2020
22
22

Real-world assessment of the BRAF status in non-squamous cell lung carcinoma using VE1 immunohistochemistry: A single laboratory experience (LPCE, Nice, France).
Véronique Hofman, Jonathan Benzaquen, Simon Heeke, Sandra Lassalle, Michel Poudenx, Elodie Long, Elisabeth Lantéri, Olivier Bordone, Virginie Lespinet, Virginie Tanga,[...]. Lung Cancer 2020
8
25

Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer.
Bob T Li, Egbert F Smit, Yasushi Goto, Kazuhiko Nakagawa, Hibiki Udagawa, Julien Mazières, Misako Nagasaka, Lyudmila Bazhenova, Andreas N Saltos, Enriqueta Felip,[...]. N Engl J Med 2022
99
22

Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
P Garrido, E Conde, J de Castro, J J Gómez-Román, E Felip, L Pijuan, D Isla, J Sanz, L Paz-Ares, F López-Ríos. Clin Transl Oncol 2020
35
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.